Daily-reconciled clinical-trial registry change intelligence

Name: Daily-reconciled clinical-trial registry change intelligence: site-level risk scores (A–F), 0–100 trial distress scores, enrollment velocity, results-disclosure compliance status (FDAAA 801 / EU CTIS Art.37 / UK ISRCTN), investigator and site dossiers, and a tamper-evident signed ledger of day-of-change registry events built from ClinicalTrials.gov, EU CTIS, UK ISRCTN/MHRA, FDA, SEC EDGAR, NIH RePORTER and CMS.
Creator: Eichor

EICHORManage supplier listing

Daily-reconciled clinical-trial registry change intelligence: site-level risk scores (A–F), 0–100 trial distress scores, enrollment velocity, results-disclosure compliance status (FDAAA 801 / EU CTIS Art.37 / UK ISRCTN), investigator and site dossiers, and a tamper-evident signed ledger of day-of-change registry events built from ClinicalTrials.gov, EU CTIS, UK ISRCTN/MHRA, FDA, SEC EDGAR, NIH RePORTER and CMS.

Open buyer room →

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks Eichor and files the sample in your catalog — private to you.

Start 7-day trialNothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry: Health Care TechnologyApplication Software
Instruments: equities
Categories: Alternative

Dataset card

Type: not stated
Format: Tabular (risk scores, site landscapes, roster states, registry delta records) plus explanatory text and a cryptographically signed change-event ledger; served via REST API and MCP server
Volume: Full public registry corpus (~550K+ registered studies across CT.gov, CTIS, ISRCTN) re-scanned daily, plus >3,000 indexed drugs, per-site landscapes for every scanned trial, and a maintained FDAAA view currently flagging 1,323 overdue trials with ~15 new additions per week; the licensable asset is the accumulated day-of-change event log
Users: Very small — invitation-only, small onboarding cohorts; est. tens to low hundreds of paid seats (inferred from invitation-only cohort onboarding stated across product pages and seat-based pricing of $199/mo to $999/seat/mo)
History: 3 years
Update frequency: not stated
Growth: Active — weekly Trial Enrollment Watch briefs run continuously through August 2026, multiple product lines added ($199/mo monitors, $999/seat/mo Signals, $995–$4,995 report SKUs, prepaid API credits), and a new UK disclosure product timed to regulations effective April 2026
Launched: ~2024–2025 (earliest dated public artifact is the FDAAA tracker snapshot dated 08/2025; weekly brief archive begins July 2026, and no dated content predates 2025)
Delivery: not stated
Entity mapping: not stated
Sample: not stated
Point-in-time: not stated
Licence: not stated

supplier index read from their site